These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36057778)

  • 1. Therapeutic Drug Monitoring of Lurasidone in Patients with Schizophrenia or Bipolar Disorder: A preliminary study.
    Huang CY; Lin SK
    Psychiatry Clin Neurosci; 2022 Dec; 76(12):674-675. PubMed ID: 36057778
    [No Abstract]   [Full Text] [Related]  

  • 2. Lurasidone-Induced Mania.
    Ward HB; Almeida M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31298818
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression.
    Modugula H; Kumar A
    CNS Neurol Disord Drug Targets; 2020; 19(2):109-114. PubMed ID: 32124704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lurasidone-induced anemia: Is there a need for hematological monitoring?
    Kirpekar VC; Faye AD; Bhave SH; Tadke R; Gawande S
    Indian J Pharmacol; 2019; 51(4):276-278. PubMed ID: 31571715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Series Reports on Lurasidone-Associated Mania.
    Doan LA; Williams SR; Takayesu A; Lu B
    J Clin Psychopharmacol; 2017 Apr; 37(2):264-266. PubMed ID: 28225748
    [No Abstract]   [Full Text] [Related]  

  • 6. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.
    Jaeschke RR; Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Styczeń K; Datka W
    Pharmacol Rep; 2016 Aug; 68(4):748-55. PubMed ID: 27203278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
    Nair SS; Chua CJM; Teo DCL
    East Asian Arch Psychiatry; 2021 Sep; 31(3):81-83. PubMed ID: 34588318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone associated neutropenia.
    Singh S; Ahmad H; John AP
    Aust N Z J Psychiatry; 2017 Oct; 51(10):1055. PubMed ID: 28478684
    [No Abstract]   [Full Text] [Related]  

  • 9. Lurasidone-Associated Manic Switch in a Patient With Depression: A Case Report.
    Gupta P; Singh J; Kumar N
    J Clin Psychopharmacol; 2019; 39(6):687-689. PubMed ID: 31688393
    [No Abstract]   [Full Text] [Related]  

  • 10. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders.
    Pompili M; Verzura C; Trovini G; Buscajoni A; Falcone G; Naim S; Nardella A; Sorice S; Baldessarini RJ; Girardi P
    Expert Opin Drug Saf; 2018 Feb; 17(2):197-205. PubMed ID: 28902525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone: A New Option for Older Adults with Bipolar Disorder?
    Rej S
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):160-161. PubMed ID: 28985992
    [No Abstract]   [Full Text] [Related]  

  • 12. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
    CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food Matters: Reduction of Lurasidone-Induced Nausea With Meals.
    Kolli V; Walia A; Kinnan S
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30869204
    [No Abstract]   [Full Text] [Related]  

  • 15. Lurasidone: an antipsychotic with antidepressant effects in bipolar depression?
    Keks NA; Hope J; Castle D
    Australas Psychiatry; 2016 Jun; 24(3):289-91. PubMed ID: 27036122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Lurasidone-Induced Polydipsia Complicated by Hyponatremia in a Patient With Bipolar Disorder.
    Li ST; Yeh YW
    Clin Neuropharmacol; 2021 Nov-Dec 01; 44(6):243-244. PubMed ID: 34561339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Using Lurasidone in the treatment of mental illness in childhood].
    Goryunov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11. Vyp. 2):77-85. PubMed ID: 35038851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Tolerability of Lurasidone in Children and Adolescents With Psychiatric Disorders.
    Findling RL; Goldman R; Chiu YY; Silva R; Jin F; Pikalov A; Loebel A
    Clin Ther; 2015 Dec; 37(12):2788-97. PubMed ID: 26631428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the pharmacokinetics and receptor-binding profile of lurasidone affect the clinical utility and safety of the drug in the treatment of schizophrenia.
    Macaluso M; Kazanchi H; Preskorn SH
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1317-27. PubMed ID: 26173973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.